Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


Articles published in Cancer Cell

Retrieve available abstracts of 18 articles:
HTML format
Text format



Single Articles


    February 2019
  1. HELLMANN MD, Callahan MK, Awad MM, Calvo E, et al
    Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer.
    Cancer Cell. 2019;35:329.
    PubMed     Text format    


    December 2018
  2. LEE PC, Fang YF, Yamaguchi H, Wang WJ, et al
    Targeting PKCdelta as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer.
    Cancer Cell. 2018;34:954-969.
    PubMed     Text format     Abstract available


    May 2018
  3. FRUH M, Peters S
    Genomic Features of Response to Combination Immunotherapy in Lung Cancer.
    Cancer Cell. 2018;33:791-793.
    PubMed     Text format     Abstract available


  4. LUKEY MJ, Katt WP, Cerione RA
    Targeting Therapy Resistance: When Glutamine Catabolism Becomes Essential.
    Cancer Cell. 2018;33:795-797.
    PubMed     Text format     Abstract available


  5. MOMCILOVIC M, Bailey ST, Lee JT, Fishbein MC, et al
    The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma.
    Cancer Cell. 2018;33:905-921.
    PubMed     Text format     Abstract available


    April 2018
  6. HELLMANN MD, Callahan MK, Awad MM, Calvo E, et al
    Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer.
    Cancer Cell. 2018 Apr 21. pii: S1535-6108(18)30172.
    PubMed     Text format     Abstract available


  7. HELLMANN MD, Nathanson T, Rizvi H, Creelan BC, et al
    Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.
    Cancer Cell. 2018 Apr 12. pii: S1535-6108(18)30123.
    PubMed     Text format     Abstract available


    February 2018
  8. SANCLEMENTE M, Francoz S, Esteban-Burgos L, Bousquet-Mur E, et al
    c-RAF Ablation Induces Regression of Advanced Kras/Trp53 Mutant Lung Adenocarcinomas by a Mechanism Independent of MAPK Signaling.
    Cancer Cell. 2018;33:217-228.
    PubMed     Text format     Abstract available


    January 2018
  9. GWINN DM, Lee AG, Briones-Martin-Del-Campo M, Conn CS, et al
    Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase.
    Cancer Cell. 2018;33:91-107.
    PubMed     Text format     Abstract available


    December 2017
  10. BERGER AH, Brooks AN, Wu X, Shrestha Y, et al
    High-throughput Phenotyping of Lung Cancer Somatic Mutations.
    Cancer Cell. 2017;32:884.
    PubMed     Text format    


    September 2017
  11. VAZ M, Hwang SY, Kagiampakis I, Phallen J, et al
    Chronic Cigarette Smoke-Induced Epigenomic Changes Precede Sensitization of Bronchial Epithelial Cells to Single-Step Transformation by KRAS Mutations.
    Cancer Cell. 2017;32:360-376.
    PubMed     Text format     Abstract available


  12. CLARK SJ, Molloy PL
    Smoke-Induced Changes to the Epigenome Provide Fertile Ground for Oncogenic Mutation.
    Cancer Cell. 2017;32:278-280.
    PubMed     Text format     Abstract available


    August 2017
  13. BEST MG, Sol N, In 't Veld SGJG, Vancura A, et al
    Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets.
    Cancer Cell. 2017;32:238-252.
    PubMed     Text format     Abstract available


    April 2017
  14. SCHOENFELD JD, Sibenaller ZA, Mapuskar KA, Wagner BA, et al
    O2- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.
    Cancer Cell. 2017;31:487-500.
    PubMed     Text format     Abstract available


    March 2017
  15. WIELAND E, Rodriguez-Vita J, Liebler SS, Mogler C, et al
    Endothelial Notch1 Activity Facilitates Metastasis.
    Cancer Cell. 2017;31:355-367.
    PubMed     Text format     Abstract available


    February 2017
  16. JUSTILIEN V, Ali SA, Jamieson L, Yin N, et al
    Ect2-Dependent rRNA Synthesis Is Required for KRAS-TRP53-Driven Lung Adenocarcinoma.
    Cancer Cell. 2017;31:256-269.
    PubMed     Text format     Abstract available


  17. BERNS K, Berns A
    Awakening of "Schlafen11" to Tackle Chemotherapy Resistance in SCLC.
    Cancer Cell. 2017;31:169-171.
    PubMed     Text format     Abstract available


    May 2016
  18. BRADY JJ, Chuang CH, Greenside PG, Rogers ZN, et al
    An Arntl2-Driven Secretome Enables Lung Adenocarcinoma Metastatic Self-Sufficiency.
    Cancer Cell. 2016;29:697-710.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: